#BEGIN_DRUGCARD DB04279

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
35114

# Chemical_Formula:
C7H12O5

# Chemical_IUPAC_Name:
(2S,3S)-2-hydroxy-3-(propan-2-yl)butanedioic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
3-Isopropylmalic Acid

# HET_ID:
IPM

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C7H12O5/c1-3(2)4(6(9)10)5(8)7(11)12/h3-5,8H,1-2H3,(H,9,10)(H,11,12)/t4-,5-/m0/s1

# InChI_Key:
InChIKey=RNQHMTFBUSSBJQ-WHFBIAKZSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
4279

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
176.1672

# Molecular_Weight_Mono:
176.068473494

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1A05

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
0.28

# Predicted_LogS:
-0.33

# Predicted_Water_Solubility:
8.33e+01 g/l

# Primary_Accession_No:
DB04279

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
5488912

# PubChem_Substance_ID:
46509193

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT01919

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
CC(C)[C@@H]([C@H](O)C(O)=O)C(O)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:23:10 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasm

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
D14585

# Drug_Target_1_GenBank_ID_Protein:
414355

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
leuB

# Drug_Target_1_Gene_Sequence:
>1077 bp
ATGAAAAAAATAGCCATCTTCGCCGGTGACGGCATCGGTCCGGAAATCGTGGCAGCCGCC
CGGCAAGTGCTGGATGCAGTGGATCAGGCCGCCCACCTTGGCCTGCGTTGTACCGAAGGC
CTGGTGGGCGGGGCCGCGCTGGATGCCAGCGATGATCCCTTGCCGGCGGCTTCTTTGCAG
TTGGCCATGGCGGCGGATGCAGTCATTTTGGGTGCGGTGGGCGGCCCCCGCTGGGACGCG
TATCCACCCGCCAAGCGCCCGGAACAGGGACTGCTGCGTCTGCGCAAAGGCCTGGACCTT
TATGCGAACCTGCGTCCCGCACAGATTTTTCCGCAGTTGCTGGATGCCTCGCCCCTACGC
CCGGAGCTGGTGCGCGACGTCGATATCCTGGTGGTGCGCGAGCTGACCGGGGATATCTAC
TTCGGCCAGCCACGCGGTCTGGAGGTCATCGACGGCAAGCGCCGCGGCTTTAACACCATG
GTCTATGACGAGGATGAAATTCGCCGTATCGCTCATGTGGCCTTCCGCGCTGCCCAGGGG
CGTCGCAAGCAGTTGTGCTCGGTGGACAAGGCCAATGTCCTGGAGACCACGCGTCTGTGG
CGCGAGGTGGTCACCGAGGTAGCGCGGGACTATCCCGATGTGCGGCTCAGCCACATGTAT
GTGGATAATGCCGCCATGCAACTGATCCGCGCCCCGGCACAGTTCGACGTGCTGTTGACC
GGCAATATGTTCGGCGACATTCTTTCCGACGAGGCCAGTCAATTGACTGGTTCCATCGGT
ATGCTGCCCTCGGCCTCGCTGGGCGAGGGACGGGCGATGTATGAACCCATCCATGGCTCG
GCGCCGGATATTGCCGGGCAGGACAAGGCGAATCCCCTGGCCACGATTCTATCCGTGGCG
ATGATGCTGCGGCATTCCCTCAACGCCGAACCCTGGGCGCAACGGGTGGAGGCGGCAGTG
CAGCGAGTGCTGGATCAGGGCCTGCGCACTGCGGATATTGCAGCGCCGGGAACGCCGGTA
ATCGGCACCAAAGCCATGGGTGCCGCGGTGGTCAACGCCCTGAACCTGAAGGATTGA

# Drug_Target_1_General_Function:
Energy production and conversion

# Drug_Target_1_General_References:
8282728	Kawaguchi H, Inagaki K, Kuwata Y, Tanaka H, Tano T: 3-Isopropylmalate dehydrogenase from chemolithoautotroph Thiobacillus ferrooxidans: DNA sequence, enzyme purification, and characterization. J Biochem (Tokyo). 1993 Sep;114(3):370-7.
9739088	Imada K, Inagaki K, Matsunami H, Kawaguchi H, Tanaka H, Tanaka N, Namba K: Structure of 3-isopropylmalate dehydrogenase in complex with 3-isopropylmalate at 2.0 A resolution: the role of Glu88 in the unique substrate-recognition mechanism. Structure. 1998 Aug 15;6(8):971-82.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3092

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
38463

# Drug_Target_1_Name:
3-isopropylmalate dehydrogenase

# Drug_Target_1_Number_of_Residues:
358

# Drug_Target_1_PDB_ID:
1A05

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00180	Iso_dh

# Drug_Target_1_Protein_Sequence:
>3-isopropylmalate dehydrogenase
MKKIAIFAGDGIGPEIVAAARQVLDAVDQAAHLGLRCTEGLVGGAALDASDDPLPAASLQ
LAMAADAVILGAVGGPRWDAYPPAKRPEQGLLRLRKGLDLYANLRPAQIFPQLLDASPLR
PELVRDVDILVVRELTGDIYFGQPRGLEVIDGKRRGFNTMVYDEDEIRRIAHVAFRAAQG
RRKQLCSVDKANVLETTRLWREVVTEVARDYPDVRLSHMYVDNAAMQLIRAPAQFDVLLT
GNMFGDILSDEASQLTGSIGMLPSASLGEGRAMYEPIHGSAPDIAGQDKANPLATILSVA
MMLRHSLNAEPWAQRVEAAVQRVLDQGLRTADIAAPGTPVIGTKAMGAAVVNALNLKD

# Drug_Target_1_Reaction:
(1) (1a) (2R,3S)-3-isopropylmalate + NAD+ = (2S)-2-isopropyl-3-oxosuccinate + NADH + H+

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Catalyzes the oxidation of 3-carboxy-2-hydroxy-4- methylpentanoate (3-isopropylmalate) to 3-carboxy-4-methyl-2- oxopentanoate. The product decarboxylates to 4-methyl-2 oxopentanoate

# Drug_Target_1_SwissProt_ID:
Q56268

# Drug_Target_1_SwissProt_Name:
LEU3_THIFE

# Drug_Target_1_Synonyms:
3-IPM-DH
Beta-IPM dehydrogenase
EC 1.1.1.85
IMDH

# Drug_Target_1_Theoretical_pI:
5.46

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Not Available

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
J02799

# Drug_Target_2_GenBank_ID_Protein:
146432

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
icd

# Drug_Target_2_Gene_Sequence:
>1251 bp
ATGGAAAGTAAAGTAGTTGTTCCGGCACAAGGCAAGAAGATCACCCTGCAAAACGGCAAA
CTCAACGTTCCTGAAAATCCGATTATCCCTTACATTGAAGGTGATGGAATCGGTGTAGAT
GTAACCCCAGCCATGCTGAAAGTGGTCGACGCTGCAGTCGAGAAAGCCTATAAAGGCGAG
CGTAAAATCTCCTGGATGGAAATTTACACCGGTGAAAAATCCACACAGGTTTATGGTCAG
GACGTCTGGCTGCCTGCTGAAACTCTTGATCTGATTCGTGAATATCGCGTTGCCATTAAA
GGTCCGCTGACCACTCCGGTTGGTGGCGGTATTCGCTCTCTGAACGTTGCCCTGCGCCAG
GAACTGGATCTCTACATCTGCCTGCGTCCGGTACGTTACTATCAGGGCACTCCAAGCCCG
GTTAAACACCCTGAACTGACCGATATGGTTATCTTCCGTGAAAACTCGGAAGACATTTAT
GCGGGTATCGAATGGAAAGCAGACTCTGCCGACGCCGAGAAAGTGATTAAATTCCTGCGT
GAAGAGATGGGGGTGAAGAAAATTCGCTTCCCGGAACATTGTGGTATCGGTATTAAGCCG
TGTTCGGAAGAAGGCACCAAACGTCTGGTTCGTGCAGCGATCGAATACGCAATTGCTAAC
GATCGTGACTCTGTGACTCTGGTGCACAAAGGCAACATCATGAAGTTCACCGAAGGAGCG
TTTAAAGACTGGGGCTACCAGCTGGCGCGTGAAGAGTTTGGCGGTGAACTGATCGACGGT
GGCCCGTGGCTGAAAGTTAAAAACCCGAACACTGGCAAAGAGATCGTCATTAAAGACGTG
ATTGCTGATGCATTCCTGCAACAGATCCTGCTGCGTCCGGCTGAATATGATGTTATCGCC
TGTATGAACCTGAACGGTGACTACATTTCTGACGCCCTGGCAGCGCAGGTTGGCGGTATC
GGTATCGCCCCTGGTGCAAACATCGGTGACGAATGCGCCCTGTTTGAAGCCACCCACGGT
ACTGCGCCGAAATATGCCGGTCAGGACAAAGTAAATCCTGGCTCTATTATTCTCTCCGCT
GAGATGATGCTGCGCCACATGGGTTGGACCGAAGCGGCTGACTTAATTGTTAAAGGTATG
GAAGGCGCAATCAACGCGAAAACCGTAACCTATGACTTCGAGCGTCTGATGGATGGCGCT
AAACTGCTGAAATGTTCAGAGTTTGGTGACGCGATCATCGAAAACATGTAA

# Drug_Target_2_General_Function:
Energy production and conversion

# Drug_Target_2_General_References:
10623532	Cherbavaz DB, Lee ME, Stroud RM, Koshland DE Jr: Active site water molecules revealed in the 2.1 A resolution structure of a site-directed mutant of isocitrate dehydrogenase. J Mol Biol. 2000 Jan 21;295(3):377-85.
2204109	Hurley JH, Dean AM, Sohl JL, Koshland DE Jr, Stroud RM: Regulation of an enzyme by phosphorylation at the active site. Science. 1990 Aug 31;249(4972):1012-6.
2682654	Hurley JH, Thorsness PE, Ramalingam V, Helmers NH, Koshland DE Jr, Stroud RM: Structure of a bacterial enzyme regulated by phosphorylation, isocitrate dehydrogenase. Proc Natl Acad Sci U S A. 1989 Nov;86(22):8635-9.
3112144	Thorsness PE, Koshland DE Jr: Inactivation of isocitrate dehydrogenase by phosphorylation is mediated by the negative charge of the phosphate. J Biol Chem. 1987 Aug 5;262(22):10422-5.
8905232	Oshima T, Aiba H, Baba T, Fujita K, Hayashi K, Honjo A, Ikemoto K, Inada T, Itoh T, Kajihara M, Kanai K, Kashimoto K, Kimura S, Kitagawa M, Makino K, Masuda S, Miki T, Mizobuchi K, Mori H, Motomura K, Nakamura Y, Nashimoto H, Nishio Y, Saito N, Horiuchi T, et al.: A 718-kb DNA sequence of the Escherichia coli K-12 genome corresponding to the 12.7-28.0 min region on the linkage map. DNA Res. 1996 Jun 30;3(3):137-55.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.
9298646	Link AJ, Robison K, Church GM: Comparing the predicted and observed properties of proteins encoded in the genome of Escherichia coli K-12. Electrophoresis. 1997 Aug;18(8):1259-313.
9352899	Wang FS, Whittam TS, Selander RK: Evolutionary genetics of the isocitrate dehydrogenase gene (icd) in Escherichia coli and Salmonella enterica. J Bacteriol. 1997 Nov;179(21):6551-9.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
2302

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
45757

# Drug_Target_2_Name:
Isocitrate dehydrogenase [NADP]

# Drug_Target_2_Number_of_Residues:
416

# Drug_Target_2_PDB_ID:
1PB3

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00180	Iso_dh

# Drug_Target_2_Protein_Sequence:
>Isocitrate dehydrogenase [NADP]
MESKVVVPAQGKKITLQNGKLNVPENPIIPYIEGDGIGVDVTPAMLKVVDAAVEKAYKGE
RKISWMEIYTGEKSTQVYGQDVWLPAETLDLIREYRVAIKGPLTTPVGGGIRSLNVALRQ
ELDLYICLRPVRYYQGTPSPVKHPELTDMVIFRENSEDIYAGIEWKADSADAEKVIKFLR
EEMGVKKIRFPEHCGIGIKPCSEEGTKRLVRAAIEYAIANDRDSVTLVHKGNIMKFTEGA
FKDWGYQLAREEFGGELIDGGPWLKVKNPNTGKEIVIKDVIADAFLQQILLRPAEYDVIA
CMNLNGDYISDALAAQVGGIGIAPGANIGDECALFEATHGTAPKYAGQDKVNPGSIILSA
EMMLRHMGWTEAADLIVKGMEGAINAKTVTYDFERLMDGAKLLKCSEFGDAIIENM

# Drug_Target_2_Reaction:
(1) isocitrate + NADP+ = 2-oxoglutarate + CO2 + NADPH

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
Isocitrate + NADP(+) = 2-oxoglutarate + CO(2) + NADPH

# Drug_Target_2_SwissProt_ID:
P08200

# Drug_Target_2_SwissProt_Name:
IDH_ECOLI

# Drug_Target_2_Synonyms:
EC 1.1.1.42
IDH
IDP
NADP(+)-specific ICDH
Oxalosuccinate decarboxylase

# Drug_Target_2_Theoretical_pI:
4.90

# Drug_Target_2_Transmembrane_Regions:
None

#END_DRUGCARD DB04279
